FDA Center for Drug Evaluation & Research Issues Warning Letter to Umicore Argentina S.A.
November 18, 2026
November 18, 2026
WASHINGTON, Nov. 18 (TNSdock) -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Umicore Argentina S.A. from its Center for Drug Evaluation and Research:
* * *
Recipient: Mr. Bart Sap, Chief Executive Officer, Umicore Argentina S.A., Broekstraat 31 Rue du Marais, 1000 Brussels, Belgium
(b)(6)
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
< . . .
* * *
Recipient: Mr. Bart Sap, Chief Executive Officer, Umicore Argentina S.A., Broekstraat 31 Rue du Marais, 1000 Brussels, Belgium
(b)(6)
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
< . . .
